Steve Lendaris > Baker Botts L.L.P. > New York, United States > Lawyer Profile
Baker Botts L.L.P. Offices
30 ROCKEFELLER PLAZA
NEW YORK, NEW YORK 10112-4498
NEW YORK
United States
- Firm Profile
- Go to...
Steve Lendaris
Work Department
Intellectual Property
Position
Partner
Sector Chair – Life Sciences (Firmwide)
Career
As Chair of Baker Botts’ Life Sciences IP Practice group, Steve advises clients on a wide range of biotechnology-related intellectual property issues. Whether evaluating third party patents ahead of product launches for a multinational biopharma enterprise, developing patent filing strategies around new therapeutic approaches for a leading cancer research institution, or advocating for an industry-transforming sequencing company before the Patent Trial and Appeal Board, Steve’s value-add is providing technically-informed and commercially-relevant legal advice that the scientists, the in-house legal team, and the C-suite can all understand.
Before attending law school, Steve performed his graduate school research on the protein-nucleic acid interactions underlying pre-messenger RNA splicing. Prior to graduate school, he was an assistant process development scientist at a large pharmaceutical company working on the production of recombinant blood clotting factors.
Memberships
New York State Bar
District of Columbia Bar
State Bar of California
United States Patent and Trademark Office
United States District Court for the Southern District of New York
United States Court of Appeals For The Federal Circuit
Education
J.D., University of California, Hastings College of the Law 2001
M.A., Molecular Biology, University of California, Santa Cruz 1998
B.S., Biology, University of California, San Diego 1993
Lawyer Rankings
United States > Healthcare > Life sciences
The IP and life sciences team at Baker Botts L.L.P. serves a broad client base consisting of biotech, medtech, and pharmaceutical companies. Working in close collaboration with the litigation and antitrust departments, the team dispenses ‘outstanding tactical advice’ on drug price fixing cases, class actions, and evaluations of third party IP rights. Steve Lendaris leads the practice from New York, assisting clients with biotech IP issues, product launches, and the development of patent filing strategies. San Francisco’s Michael Torosian advises emerging companies and investors on venture capital financings and IPOs, while William Lavery supports the team from Washington DC, drawing on his expertise in government investigations and antitrust litigation. Stephen Hash and Margaret Sampson left the practice in July 2022. Courtney Fore left the firm for an in-house position in May 2022.
Lawyer Rankings
Top Tier Firm Rankings
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- International Trade > Customs, export controls and economic sanctions
Firm Rankings
- Antitrust > Cartel
- Energy > Energy litigation: electric power
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Tax > US taxes: contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Labor and employment > ERISA litigation
- Dispute resolution > International arbitration
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- Energy > Renewable/alternative power
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Finance > Capital markets: equity offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Real estate > Construction (including construction litigation)
- Healthcare > Life sciences
- Real estate > Real estate
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense